Clinical Trial Update: Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy (PEA Bridging Study) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating riociguat as bridging therapy before pulmonary endarterectomy in operable CTEPH; the study status is terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cteph
• Thromboembolic Pulmonary Hypertension

Drugs mentioned

• Riociguat (riociguat)

Snippet

Sponsor: International CTEPH Association | Conditions: Chronic Thromboembolic Pulmonary Hypertension, CTEPH | Phase 2 | Status: TERMINATED | Results posted: 2021-06-22